Life Sciences: Corporate/Commercial
California
20 years ranked
Provided by Wilson Sonsini Goodrich & Rosati
Ken Clark serves as general counsel to companies and their boards of directors, primarily in the biotechnology industry. Ken has extensive expertise in partnering and strategic transactions, having negotiated more than 100 major strategic alliance and M&A transactions. He also regularly represents companies in financings, spin-outs, and related matters.
Ken served on the firm's board of directors from 2011 to 2014 and from 2002 to 2006, and previously was a member of the firm's Policy Committee. Ken served as a director of Pharmacyclics, Inc. (NASDAQ: PCYC) from 2012 until their sale to AbbVie in 2015.
Provided by Chambers
Kenneth Clark is frequently called upon to represent life sciences clients in a broad array of corporate transactions including strategic agreements, M&A, financings and spinouts.
Provided by Chambers
Kenenth is an excellent attorney with a great reputation for medical devices work.
Kenneth is a well-known attorney who is easy to work with and produces high-quality work.
Chambers is the leading data and intelligence partner for the legal sector.